187 related articles for article (PubMed ID: 30234607)
1. Interferon lambda 3/4 polymorphisms are associated with AIDS-related Kaposi's sarcoma.
Bibert S; Wójtowicz A; Taffé P; Tarr PE; Bernasconi E; Furrer H; Günthard HF; Hoffmann M; Kaiser L; Osthoff M; Fellay J; Cavassini M; Bochud PY;
AIDS; 2018 Nov; 32(18):2759-2765. PubMed ID: 30234607
[TBL] [Abstract][Full Text] [Related]
2. Occult hepatitis C virus infection in hemophilia patients and its correlation with interferon lambda 3 and 4 polymorphisms.
Nafari AH; Ayadi A; Noormohamadi Z; Sakhaee F; Vaziri F; Siadat SD; Fateh A
Infect Genet Evol; 2020 Apr; 79():104144. PubMed ID: 31838260
[TBL] [Abstract][Full Text] [Related]
3. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma.
Renwick N; Halaby T; Weverling GJ; Dukers NH; Simpson GR; Coutinho RA; Lange JM; Schulz TF; Goudsmit J
AIDS; 1998 Dec; 12(18):2481-8. PubMed ID: 9875587
[TBL] [Abstract][Full Text] [Related]
4. Changing patterns of Kaposi's sarcoma in Danish acquired immunodeficiency syndrome patients with complete follow-up. The Danish Study Group for HIV Infection (DASHI).
Lundgren JD; Melbye M; Pedersen C; Rosenberg PS; Gerstoft J
Am J Epidemiol; 1995 Apr; 141(7):652-8. PubMed ID: 7702040
[TBL] [Abstract][Full Text] [Related]
5. AIDS-associated Kaposi's sarcoma is linked to advanced disease and high mortality in a primary care HIV programme in South Africa.
Chu KM; Mahlangeni G; Swannet S; Ford NP; Boulle A; Van Cutsem G
J Int AIDS Soc; 2010 Jul; 13():23. PubMed ID: 20615222
[TBL] [Abstract][Full Text] [Related]
6. Single Nucleotide Polymorphism Analysis in HIV and Kaposi's Sarcoma Disease by Microarray Technique.
Koyuncu I; Gönel A; Ozcan E; Temiz E; Toprak Ş; Akkafa F; Binici I
Curr HIV Res; 2020; 18(3):154-164. PubMed ID: 32539678
[TBL] [Abstract][Full Text] [Related]
7. Kaposi's sarcoma in HIV infection: impact on opportunistic infections and survival.
Brodt HR; Kamps BS; Helm EB; Schöfer H; Mitrou P
AIDS; 1998 Aug; 12(12):1475-81. PubMed ID: 9727568
[TBL] [Abstract][Full Text] [Related]
8. Kaposi's sarcoma and central nervous system disease: a real association or an artifact of the control group? Terry Beirn Community Programs for Clinical Research on AIDS.
Eberly LE; Ohman PA; Neaton JD; Price RW; Abrams DI
AIDS; 2000 May; 14(8):995-1000. PubMed ID: 10853981
[TBL] [Abstract][Full Text] [Related]
9. [AIDS-associated Kaposi's sarcoma: 22 cases].
Dhrif AS; Kilani B; Ammari L; Kanoun F; Tiouri H; Ben Chaaben T
Tunis Med; 2007 Jun; 85(6):494-9. PubMed ID: 17644904
[TBL] [Abstract][Full Text] [Related]
10. Clinico-epidemiologic characteristics and patterns of care in Kaposi's sarcoma: Data from a single-institution series.
Hwang A; Iskandar AS; Kerr WT; Farrell S; Plaxe SC; Dasanu CA
J Oncol Pharm Pract; 2019 Oct; 25(7):1719-1721. PubMed ID: 30940048
[TBL] [Abstract][Full Text] [Related]
11. The association between interferon lambda 3 and 4 gene single-nucleotide polymorphisms and the recovery of COVID-19 patients.
Rahimi P; Tarharoudi R; Rahimpour A; Mosayebi Amroabadi J; Ahmadi I; Anvari E; Siadat SD; Aghasadeghi M; Fateh A
Virol J; 2021 Nov; 18(1):221. PubMed ID: 34775984
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a sexually transmitted cofactor for AIDS-related Kaposi's sarcoma in a cohort of homosexual men.
Archibald CP; Schechter MT; Le TN; Craib KJ; Montaner JS; O'Shaughnessy MV
Epidemiology; 1992 May; 3(3):203-9. PubMed ID: 1591318
[TBL] [Abstract][Full Text] [Related]
13. Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma.
Engels EA; Biggar RJ; Marshall VA; Walters MA; Gamache CJ; Whitby D; Goedert JJ
AIDS; 2003 Aug; 17(12):1847-51. PubMed ID: 12891072
[TBL] [Abstract][Full Text] [Related]
14. Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group.
Mocroft A; Youle M; Gazzard B; Morcinek J; Halai R; Phillips AN
AIDS; 1996 Sep; 10(10):1101-5. PubMed ID: 8874626
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.
Ziegler JL; Newton R; Katongole-Mbidde E; Mbulataiye S; De Cock K; Wabinga H; Mugerwa J; Katabira E; Jaffe H; Parkin DM; Reeves G; Weiss R; Beral V
AIDS; 1997 Nov; 11(13):1619-26. PubMed ID: 9365767
[TBL] [Abstract][Full Text] [Related]
16. Composite risk score for Kaposi's sarcoma based on a case-control and longitudinal study in the Multicenter AIDS Cohort Study (MACS) population.
Armenian HK; Hoover DR; Rubb S; Metz S; Kaslow R; Visscher B; Chmiel J; Kingsley L; Saah A
Am J Epidemiol; 1993 Aug; 138(4):256-65. PubMed ID: 8356966
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis and treatment of HIV-related Kaposi's sarcoma].
Reyners AK; Sprenger HG; Suurmeijer AJ; van der Graaf WT
Ned Tijdschr Geneeskd; 2006 Mar; 150(11):589-93. PubMed ID: 16610494
[TBL] [Abstract][Full Text] [Related]
18. Clinical manifestations of classical, endemic African, and epidemic AIDS-associated Kaposi's sarcoma.
Friedman-Kien AE; Saltzman BR
J Am Acad Dermatol; 1990 Jun; 22(6 Pt 2):1237-50. PubMed ID: 2193952
[TBL] [Abstract][Full Text] [Related]
19. The epidemiology of classic, African, and immunosuppressed Kaposi's sarcoma.
Wahman A; Melnick SL; Rhame FS; Potter JD
Epidemiol Rev; 1991; 13():178-99. PubMed ID: 1765111
[TBL] [Abstract][Full Text] [Related]
20. Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma.
Plettenberg A; Albrecht D; Lorenzen T; Meyer T; Arndt R; Stoehr A
Eur J Med Res; 2002 Jan; 7(1):19-24. PubMed ID: 11827836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
